Not Yet RecruitingNot Applicable

It is Accepted That Adenoid Hypertrophy is Related to Otitis Media With Effusion Incidence. Better Understanding of the Correlation Between the Relative Size of AH and the Incidence of Persistent OME May Provide Evidence to Support a More Standardized Approach to the Diagnosis and Treatment of OME.

60 participantsStarted 2025-05

Plain-language summary

The aim of this study is to further investigate the correlation between Site and size of adenoid hypertrophy and middle ear effusion in order to provide evidence for designing a more standardized approach to the diagnosis and treatment of OME.

Who can participate

Age range1 Year – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children (until age of 16 years old). * Patients with adenoid hypertrophy. * Patients with OME. Exclusion Criteria: * Children known to have cleft palate, submucous cleft palate or other medical problems causing velopharyngeal insufficiency. * Down's syndrome, septal deviation, primary ciliary dyskinesia (Kartagener's syndrome), previous head or ear trauma, or previous myringotomy with ventilation tube insertion * Systemic medical problems interfering with surgery. * Refusal of parents to participate. * Craniofacial abnormalities.

What they're measuring

Comparing presence of middle ear effusion in relation to site and size of adenoid hypertrophy

Timeframe: Baseline

Trial details

NCT IDNCT06674720

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-05

Contact for this trial

Esraa A Mohamed, Bachelor's

+201122736706 esraa.aboalqasem@gmail.com

View on ClinicalTrials.gov More Adenoid Hypertrophy trials